8-Hydroxy Quinaldine

8-Hydroxy Quinaldine

SCHEMBL1714541

Cc1ccc2cccc([O-])c2n1.Cc1ccc2cccc([O-])c2n1.[Be+2]

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 1/20 0.57
CCR1 P32246 1/20 0.56
RAB9A P51151 1/20 0.56
CCR5 P51681 1/20 0.56
PARP1 P09874 1/20 0.49
GLO1 Q04760 2/20 0.46
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
TDP1 Q9NUW8 1/20 0.44
CYP1A2 P05177 1/20 0.43
BDKRB2 P30411 1/20 0.42
AGTR1 P30556 1/20 0.41
PAX8 Q06710 1/20 0.41
SLC40A1 Q9NP59 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
NFKBIA P25963 1/20 0.39
RELA Q04206 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
8-Hydroxy Quinaldine SCHEMBL1147958 0.96 METAP2 (0.53) METAP2CCR1RAB9ACCR5PARP1
8-Hydroxy Quinaldine SCHEMBL6364851 0.96 METAP2 (0.53) METAP2CCR1RAB9ACCR5PARP1
8-Hydroxy Quinaldine SCHEMBL31268359 0.96 METAP2 (0.57) METAP2CCR1RAB9ACCR5PARP1
8-Hydroxy Quinaldine SCHEMBL1133461 0.96 METAP2 (0.57) METAP2CCR1RAB9ACCR5PARP1
8-Hydroxy Quinaldine SCHEMBL28411870 0.96 METAP2 (0.57) METAP2CCR1RAB9ACCR5PARP1
8-Hydroxy Quinaldine SCHEMBL546578 0.96 METAP2 (0.57) METAP2CCR1RAB9ACCR5PARP1
8-Hydroxy Quinaldine SCHEMBL546344 0.96 METAP2 (0.57) METAP2CCR1RAB9ACCR5PARP1
8-Hydroxy Quinaldine SCHEMBL2059590 0.96 METAP2 (0.57) METAP2CCR1RAB9ACCR5PARP1
8-Hydroxy Quinaldine SCHEMBL1714719 0.96 METAP2 (0.57) METAP2CCR1RAB9ACCR5PARP1
8-Hydroxy Quinaldine SCHEMBL1715251 0.96 METAP2 (0.57) METAP2CCR1RAB9ACCR5PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1486549-B1 ORGANIC ELECTROLUMINESCENT ELEMENT TOYOTA JIDOSHOKKI KK (JP) 2012-01-11 EP disclosed
EP-1755362-B1 ORGANIC EL DEVICE TOYOTA JIDOSHOKKI KK (JP) 2011-07-20 EP disclosed
US-7854998-B2 Organic EL devices KABUSHIKI KAISHA TOYOTA JIDOSHOKKI (JP) 2010-12-21 US disclosed
EP-1489154-B1 ORGANIC ELECTROLUMINESCENCE DEVICE TOYOTA JIDOSHOKKI KK (JP) 2009-05-13 EP disclosed
US-7521567-B2 Amine compound and uses thereof KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 2009-04-21 US disclosed
US-20080290788-A1 Organic el Devices KABUSHIKI KAISHA TOYOTA JIDOSHOKKI (JP) 2008-11-27 US disclosed
US-7419727-B2 Organic electroluminescent device KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 2008-09-02 US disclosed
US-7338720-B2 Organic electroluminescent element KABUSHIKI KAISHA TOYOTA JIDOSHOKKI (JP) 2008-03-04 US disclosed
US-7252892-B2 Organic electroluminescence device KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 2007-08-07 US disclosed
EP-1755362-A1 ORGANIC EL DEVICE KABUSHIKI KAISHA TOYOTA JIDOSHOKKI (JP) 2007-02-21 EP disclosed
US-20070018568-A1 Organic electroluminescent device KABUSHIKI KAISHA TOYOTA JIDOSHOKKI (JP) 2007-01-25 US disclosed
US-20060228577-A1 Organic electroluminescent device KABUSHIKI KAISHA TOYOTA JIDOSHOKKI (JP) 2006-10-12 US disclosed
US-20060226421-A1 Amine compound and uses thereof KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KENKYUJO (JP) 2006-10-12 US disclosed
US-20060192473-A1 Organic electroluminescent device KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 2006-08-31 US disclosed
EP-1599074-A1 ORGANIC ELECTROLUMINESCENT DEVICE Kabushiki Kaisha Toyota Jidoshokki (JP) 2005-11-23 EP disclosed
EP-1560469-A1 ORGANIC ELECTROLUMINESCENT DEVICE Kabushiki Kaisha Toyota Jidoshokki (JP) 2005-08-03 EP disclosed
US-20050089713-A1 Organic electroluminescent element KABUSHIKI KAISHA TOYOTA JIDOSHOKKI (JP) 2005-04-28 US disclosed
US-20050084707-A1 Organic electroluminescence device KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 2005-04-21 US disclosed
EP-1489154-A1 ORGANIC ELECTROLUMINESCENCE DEVICE Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo (JP) 2004-12-22 EP disclosed
EP-1486549-A1 ORGANIC ELECTROLUMINESCENT ELEMENT Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo (JP) 2004-12-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060226421-A1 Amine compound and uses thereof PNMT, TYR, PAM METAP2 560/4885CCR1 4017/4885RAB9A 2372/4885
US-20050084707-A1 Organic electroluminescence device ELAVL1, SELE, CELF2 METAP2 4464/4885CCR1 4055/4885RAB9A 4324/4885
US-20050089713-A1 Organic electroluminescent element SOD3, CELF2, SOD1 METAP2 4353/4885CCR1 4096/4885RAB9A 4581/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.